Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis

NCT00622687 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped sufficient number to reach the primary endpoint and as planned

Conditions

Systemic Sclerosis

Interventions

DRUG: iloprost
DRUG: iloprost low dose
DRUG: iloprost therapy up to 2 ng/kg x min

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]